Live
- NBW against ex-BJD MP, 5 others in tribal murder case
- Combing operations on against Maoists, weapons recovered: HM
- Delhi's winter action plan: Govt to set up 250 tents for homeless individuals
- Naik reviews drinking water project
- Eureka! 2 young innovators unleash creativity, dish out AI-enabled solutions
- Worst in the country: Air quality hits severe
- ECoR to upgrade overhead electrification
- Only LG can make policy for bus marshals: AAP
- SC halts bulldozer action by States
- Sindhu movers to pre-quarters, Lakshya bows out
Roche brings cancer drug to India
Drug firm Roche India on Thursday said it has launched Atezolizumab used for the treatment of small cell lung cancer in India after getting nod from Drugs Controller General of India.
New Delhi: Drug firm Roche India on Thursday said it has launched Atezolizumab used for the treatment of small cell lung cancer in India after getting nod from Drugs Controller General of India.
"Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of extensive-stage small cell lung cancer (ES-SCLC) when given in combination with chemotherapy," Roche India said in a statement.
The cancer immunotherapy harnesses the person's immune system to combat cancer more effectively for better results, it added.
"Roche is committed to bring to India all the innovations being developed in its pipeline, to benefit patients," Lara Bezerra, chief purpose officer at Roche Products (India) said.
Launching Atezolizumab is an important step for small cell lung cancer patients in India, she added.
